Research Applications and Methodology
Anabolicum Nordic Fusion is a research-grade preparation containing LGD-4033 (Ligandrol), a non-steroidal selective androgen receptor modulator extensively studied in laboratory settings. Researchers at Stroid UK Shop utilise this compound to investigate selective tissue-targeting mechanisms and androgen receptor binding dynamics. The high-affinity binding properties of LGD-4033 make it particularly valuable for studies examining tissue-selective androgenic activity in preclinical models, offering researchers insights into muscle and bone tissue responses without the broader systemic effects observed with traditional androgens.
Chemical Profile and Laboratory Specifications
LGD-4033 demonstrates exceptional selectivity for androgen receptors in muscle and bone tissue, with reduced androgenic effects on prostate tissue in animal models. This compound has advanced through Phase I clinical trials, providing researchers with comprehensive data on its pharmacokinetic properties and tissue distribution patterns. Scientists investigating LGD-4033 research applications benefit from its oral bioavailability and documented binding affinity characteristics. The Nordic Fusion formulation maintains strict quality standards essential for reproducible research outcomes in laboratory environments studying androgen receptor modulation pathways.
Analytical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | LGD-4033 (Ligandrol) |
| CAS Number | 1165910-22-4 |
| Molecular Formula | C₁₄H₁₂F₆N₂O |
| Molecular Weight | 338.25 g/mol |
| Storage Conditions | Room temperature, protected from moisture |
| Research Classification | Selective Androgen Receptor Modulator |
Researchers studying SARM mechanisms appreciate the documented tissue selectivity profile that distinguishes LGD-4033 from other research compounds. The molecular structure enables researchers to examine specific androgen receptor activation patterns while maintaining experimental controls. Studies comparing peptide-based approaches with SARM methodology often utilise LGD-4033 as a reference standard for non-peptide selective receptor modulation research.
Research Use Compliance
Anabolicum Nordic Fusion is manufactured exclusively for in-vitro research applications and is not intended for human consumption. This product is designed for qualified researchers conducting studies in approved laboratory facilities. All research must comply with institutional guidelines and local regulations governing the use of research compounds in experimental settings.
